Clinical Trial Update: Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial safety results for inhaled insulin in adults with Type 1 and Type 2 diabetes are reported. The study is completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Afrezza (Technosphere insulin)

Snippet

Sponsor: Mannkind Corporation | Conditions: Diabetes, Type 1, Diabetes, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2014-10-16